secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2026-08-25T20:15:44+00:00
Accession:  0001193125-26-365150
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion sets Sept 4, 2026 record date for CVR distribution in Korsana merger
------------------------------------------------------------------------------

- Record date of Sept 4, 2026 fixed for contingent value rights (CVRs) to holders of common stock and Series A Preferred.
- CVRs issued in connection with planned merger with Korsana Biosciences; merger still pending shareholder approval.
- CVR payment date, number of CVRs, and terms (transferability, listing) not yet disclosed.
- Merger completion remains subject to closing conditions, including obtaining required approvals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000119312526365150/0001193125-26-365150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000119312526365150/d376250d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-365150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer